Theresa Wingrove, SVP OF REGULATORY AFFAIRS at ImmunoGen, Inc. (IMGN), sold 117,445 shares at $29.40 ($3.5M) on 2023-12-15, disclosed to the SEC on 2023-12-19.
Scheduled sale ($3.5M) by SVP OF REGULATORY AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IMGN | SELL | 2023-12-01 | $9.7M | — | Filing → |
| IMGN | SELL | 2023-11-17 | $5.3M | — | Filing → |
| IMGN | SELL | 2023-11-08 | $650K | — | Filing → |